The Health Insurer That Loses Money While Gaining Everything Else

A Company That Grows Fast and Bleeds Slowly

Let us introduce Niva Bupa Health Insurance — a company that, depending on your perspective, is either a high-growth compounder in its investment phase, or a loss-making insurer charging you premiums it can’t quite cover with claims. Both perspectives contain truth. That’s what makes it interesting.

The company has been around since 2010, started as a Max India–Bupa joint venture, then True North’s PE money came in, the company went public in November 2024, and now Bupa Singapore Holdings Pte Ltd holds 55.36% — firmly in the promoter chair. In FY25, the company finally turned profitable with ₹214 crore PAT. Q3 FY26 erased that progress by posting ₹-88 crore. The culprits? A combination of the 1/n accounting method mandated by IRDAI, seasonality in claims, and a combined operating ratio running at 114.1%. For the uninitiated — anything above 100% means the insurer is spending more than it earns on premiums. Niva Bupa is at 114%. That’s not a red flag, that’s an entire red parade.

And yet — GWP grew 32% in 9M FY26. Retail market share hit 10%. Digital channel grew 70% in Q3. ReAssure 3.0 became the fastest-growing product. Management is calling it a “profitability step-up” phase. And the 9M IFRS PAT is ₹208 crore, up 74% YoY. So depending on which accounting lens you use, the company is either thriving or struggling. Welcome to the world of standalone health insurance. Pack Paracetamol.

They Sell You Health Insurance. You File Claims. They Hope the Math Works Out.

The business model of a health insurer is theoretically elegant: collect premiums from healthy people, pay claims of sick people, invest the float in between, and pocket the difference. In practice, it is considerably messier — especially when your claims ratio is 74.3% and your expense ratio is 39.9%, making your combined ratio a delightful 114.1%.

Niva Bupa operates exclusively in health insurance — no motor, no fire, no marine. Just health. This is called a “standalone health insurer” (SAHI), and India has exactly four of them in the listed space. The company covers 23.1 million active lives, has 10,507 network hospitals, and processes claims with a 94.6% settlement ratio. Their distribution spans 209 branches, 2.09 lakh individual agents, 563 brokers (including Policybazaar), and a fast-growing direct digital channel.

Product mix: 68% Retail Health, 30% Group Health, ~2% PA & Travel. Management is intentionally under-growing the Group Health segment (which has a worse loss ratio) and pushing Retail — where margins and stickiness are better. ReAssure 3.0, their flagship unlimited sum insured retail product, is doing the heavy lifting on new business growth. The OPD and wellness features are sticky enough to reduce churn, which is the single most valuable thing a health insurer can build.

Q3 FY26: Growing Revenue, Bleeding PAT